Our commercialisation successes
As a testament to the quality and relevance of UTS research, we have enjoyed many successful commercialisation outcomes. Here are a few examples of where UTS research is generating real impact in the commercial world.
UTS ithree institute disease research has led to the formation of a new company, Auspherix Pty Ltd, that will explore the commercial potential of drugs to fight infections caused by bacteria that have become resistant to currently available antibiotics.
The company has received a $1m investment from Australia’s Medical Research Commercialisation Fund (MRCF) and will pursue development of new antibacterial drugs based on intellectual property arising from discoveries made by the Institute's Director, Professor Ian Charles and fellow researcher Dr Dagmar Alber.
The initial investment by the MRCF will be used to explore ways to improve the antibiotic activity of drugs that have been identified through a screening program undertaken at the ithree institute and to establish initial safety and efficacy data in in vivo models.
Helmedix Pty Ltd is developing new therapies for autoimmune diseases. The company has identified peptides derived from helminthic worms that have immune-modulating properties. These peptides are being explored as novel approach to treating autoimmune diseases such as rheumatoid arthritis, colitis, psoriasis and multiple sclerosis.
Helmedix is currently focused on a program to progress lead optimisation and pre-clinical development of the helminth-derived peptides. The Helmedix technology originated from the team of Dr Sheila Donnelly at the ithree institute in Sydney.
Sabre Autonomous Solutions
Sydney robotics start-up, Sabre Autonomous Solutions Pty Ltd, has received a major investment from Australian company, Burwell Technologies, to commercialise the world’s first autonomous grit-blasting robot.
Sabre is a new Australian robotics company formed by the University of Technology, Sydney (UTS).
Grit-blasting is used in many industries for cleaning and preparing steel for corrosion protection and for cleaning stone and concrete.
The investment will help Sabre refine the robot’s unique capabilities to autonomously sense and map a steel structure, and then plan a suitable collision-free grit-blasting pathway, so that human workers can operate outside the blasting zone.
The robot can also perform work on areas that are difficult for humans to reach, such as corners, upper beams, ceilings and roofs, without additional scaffolding.
The intellectual property underpinning Sabre’s technology originated from a team led by Professor Dikai Liu of the Centre for Autonomous Systems within the Faculty of Engineering and Information Technology at UTS, in collaboration with Roads and Maritime Services NSW over the past six years.
Please visit the Sabre website for more details www.sabreautonomous.com.au